Navigation Links
NRI Doctor's R&D Model in India to Slash Cost of Drugs

A British doctor of Indian origin and his colleague are set to drastically lower the cost of medicines //and pose a challenge to the monopoly of multinational drug companies.

Sunil Shaunak, professor of infectious diseases at Imperial College, London, and Steve Brocchini from the London School of Pharmacy are leading clinical trials in India for a drug for hepatitis C.

The two academics have devised a way to invent new medicines and get them to market at a fraction of the cost charged by big drug companies. Their model is likely to enable millions in poor countries to be cured of infectious diseases and reduce the drugs bill of Britain's National Health Service.

The Guardian reported Tuesday that Shaunak called their revolutionary new model "ethical pharmaceuticals". Improvements devised to the molecular structure of an existing, expensive drug turned it technically into a new medicine, which was no longer under a 20-year patent to a multinational drug company and could be made and sold cheaply.

"The process has the potential to undermine the monopoly of the big drug companies and bring cheaper drugs not only to poor countries but back to the UK," the newspaper reported.

It added that Shaunak and Brocchini had linked up with an unnamed Indian biotech company, which will manufacture the first drug - for hepatitis C - if clinical trials in India are successful. The report added that the trials are sponsored by the Indian government.

Hepatitis C reportedly affects 170 million people worldwide and at least 200,000 in Britain.

Multinational drug companies put the cost of the research and development of a new drug at $800 million. According to Shaunak and Brocchini, the cost of developing their drug will be only a few million pounds.

The report added that Imperial College would hold the patent on the hepatitis C drug to prevent anybody attempting to block its development. The college employs top patent lawyers who also work for some of the big pharmaceutical companies.

"Once the drugs have passed through clinical trials and have been licensed in India, the same data could be used to obtain a European licence so that they could be sold to the NHS as well," the report said.

Shaunak told the newspaper that it was time that the monopoly on drug invention and production by multinational corporations - which charge high prices because they need to make big profits for their shareholders - was broken.

"The pharmaceutical industry has convinced us that we have to spend billions of pounds to invent each drug. We have spent a few millions. Yes, it will be a threat to the monopoly that there is.

"I'm not only an inventor of medicines - I'm an end user. We have become so completely dependent on the big pharmaceutical industry to provide all the medicines we use. Why should we be completely dependent on them when we do all the creative stuff in the universities?

"Maybe the time has come to say why can't somebody else do it? What we have been struck by is that once we have started to do it, it is not so difficult."

The team's work on the hepatitis C drug is supported by a grant from the Wellcome Trust and help and advice from the Department for Trade and Industry and the Foreign and Commonwealth Office.

The report added that the "ethical pharmaceutical" model was unlikely to find much favour with the multinational pharmaceutical companies, which already employed large teams of lawyers to defend the patents which they describe as the lifeblood of the industry.

Source-Newswise
'"/>




Related medicine news :

1. Kiwi veterinarians angry Over Doctors Advice
2. Doctors strike called off in Maharashtra
3. Doctors AIDS Documentary Focus on Stigma and Discrimination
4. Researchers Develop Mouse Model Of Brain Tumor
5. New Model for understanding Tumor Metastasis
6. Mathematical Model Can Now Help Predict Asthma Risk
7. Model Kate Moss - Re-Birth After Humiliation
8. Womens Self-Esteem Not Lowered By Seeing Ultra Thin Models
9. India Can Become A Role Model In Combating HIV Infections
10. Mouse Models To Determine The Cause Of Aggressive Leukemia
11. Aussie Model Macpherson Hated Tall Figure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
Breaking Medicine Technology: